Your browser doesn't support javascript.
loading
Development of Ultrapure and Potent Tannic Acids as a Pan-coronal Antiviral Therapeutic.
Shih, Po-Chang; Mao, Yi-Wen; Hu, Jhe-Wei; Hsieh, Han-Yi; Shih, Tsai-Miao; Lu, Lu-Ping; Chang, Wei-Hua; Huang, Chan-Hui; Lin, Chia-Hung; Lin, Chih-Hung; Tan, Peng; Yang, Ya-Ching; Chien, Ming-Hong; Su, Chen-Che; Yeh, Cheng-Hsin; Chuang, Pei-Yun; Hsieh, Tien-Lan; Wang, Ching-Cheng; Hsieh, Po-Shiuan; Chou, Teh-Ying; Tsai, Guochuan Emil.
Afiliación
  • Shih PC; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Mao YW; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Hu JW; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Hsieh HY; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Shih TM; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Lu LP; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Chang WH; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Huang CH; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Lin CH; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Lin CH; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Tan P; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Yang YC; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Chien MH; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Su CC; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Yeh CH; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Chuang PY; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Hsieh TL; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Wang CC; Department of Research and Development, SyneuRx International (Taiwan) Corp., New Taipei City 22175, Taiwan.
  • Hsieh PS; Institute of Physiology, National Defense Medical Center, Taipei City 11490, Taiwan.
  • Chou TY; Department of Medical Research, Tri-Service General Hospital, Taipei City 114, Taiwan.
  • Tsai GE; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei City 112, Taiwan.
ACS Pharmacol Transl Sci ; 5(6): 400-412, 2022 Jun 10.
Article en En | MEDLINE | ID: mdl-37582235
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos